Posts Tagged ‘Pfizer Inc.’

Pfizer Inc. (PFE) Reports Earnings

Pfizer Inc. reported that its third-quarter profit dropped 19 percent as generic competition continued to cut sales, while lower operational expenses failed to offset higher taxes and one-time charges. The company said net income was $2.59 billion, or 39 cents per share, down from $3.21 billion, or 43 cents per share, a year earlier. Excluding […]

Pfizer Reports Earnings

Pfizer Inc. (PFE) reported second-quarter net income more than quadrupled, helped by the sale of its animal health business. Earnings beat Wall Street’s earnings expectations but revenue continued to decline as patents expire on drugs that had once been blockbusters for the company. Pfizer, which makes Viagra, Lyrica and Celebrex, earned $14.1 billion, or $1.98 […]


Warning: Invalid argument supplied for foreach() in /home/customer/www/dow-jones-djia.com/public_html/wp-includes/script-loader.php on line 2781